Original study
Mechanism of the suppression of repetitive atrial firing by isoproterenol — comparison with disopyramide

https://doi.org/10.1016/0167-5273(94)90006-XGet rights and content

Abstract

To investigate whether isoproterenol (Iso) could suppress the initiation of repetitive atrial firing (RAF), we investigated its effect on RAF in comparison with that of disopyramide (Diso). Extrastimuli at a basic cycle length of 500 ms were delivered from the high right atrium in 49 patients who received an intravenous infusion of Iso (0.01 μg/kg per min) and in 39 patients given intravenous Diso (2 mg/kg per 10 min). Induction of RAF, the atrial effective refractory period (A-ERP), and the maximum conduction delay (MCD) were measured. Iso abolished the induction of RAF in 1319 (68%) patients, while Diso did so in 1322 (59%) patients. Thirty-four of the 41 patients with RAF in the base-line study had an A-ERP <250 ms and an MCD >40 ms. Iso significantly decreased the A-ERP from 205 ± 26 to 194 ± 23 ms (P < 0.01) and significantly decreased the MCD from 67 ± 24 to 39 ± 16 ms (P < 0.0001) in 19 patients with RAF. On the other hand, Diso significantly increased the A-ERP from 203 ± 31 to 235 ± 36 ms (P < 0.0001), and significantly diminished the MCD from 68 ± 31 to 55 ± 30 ms (P < 0.01) in 22 patients with RAF. In patients with new RAF (n = 7) or re-induced RAF (n = 14) during Iso or after Diso, the MCD was more than 40 ms. Our results suggest that there are two different modes of RAF suppression, i.e. shortening or lengthening of the A-ERP. Thus, suppression of RAF is probably due to a reduction of conduction delay, with Iso accelerating conduction and Diso diminishing conduction delay as a result of prolongation of the A-ERP.

References (24)

  • A Konoe et al.

    Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation

    PACE

    (1992)
  • TR Engle et al.

    Diagnostic implications of atrial vulnerability

    PACE

    (1979)
  • Cited by (13)

    • Mechanisms of termination and prevention of atrial fibrillation by drug therapy

      2011, Pharmacology and Therapeutics
      Citation Excerpt :

      AF vulnerability or incidence were consistently increased, but effects on other electrophysiological parameters were variable (Table 1). For example, in patients, isoprenaline caused a marked increase in conduction velocity and a small decrease in ERP, thus increasing wavelength (Shimizu et al., 1994), whereas in dogs, isoprenaline had no effect on wavelength (Rensma et al., 1988). Furthermore, adrenaline prolonged ERP in rabbit atria in-vitro (Smeets et al., 1986), whilst isoprenaline had no effect on ERP in human atrial isolated cells (Redpath et al., 2006).

    • Cardiac adrenergic control and atrial fibrillation

      2010, Naunyn-Schmiedeberg's Archives of Pharmacology
    View all citing articles on Scopus
    View full text